Unison Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-25,422
| Closed | -$921K | – | 199 |
|
|
2023
Q1 | $921K | Hold |
25,422
| – | – | 0.1% | 85 |
|
|
2022
Q4 | $907K | Hold |
25,422
| – | – | 0.12% | 84 |
|
|
2022
Q3 | $861K | Buy |
25,422
+5,935
| +30% | +$201K | 0.16% | 80 |
|
|
2022
Q2 | $563K | Hold |
19,487
| – | – | 0.15% | 91 |
|
|
2022
Q1 | $630K | Hold |
19,487
| – | – | 0.15% | 88 |
|
|
2021
Q4 | $568K | Hold |
19,487
| – | – | 0.14% | 96 |
|
|
2021
Q3 | $519K | Hold |
19,487
| – | – | 0.13% | 91 |
|
|
2021
Q2 | $600K | Hold |
19,487
| – | – | 0.11% | 85 |
|
|
2021
Q1 | $510K | Hold |
19,487
| – | – | 0.1% | 90 |
|
|
2020
Q4 | $491K | Buy |
+19,487
| New | +$491K | 0.11% | 79 |
|